Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Biogen Wins Tecfidera Patent Case
Investopedia
Wed, 03/22/17 - 10:02 am
Tags:
Biogen, Tecfidera, patents, Kyle Bass, MS, multiple sclerosis
The new CEOs in biopharma are joining the big players at the billion-dollar chip table
Endpoints
Fri, 03/10/17 - 09:16 pm
Tags:
Pharma CEOs, M&A, Eli Lilly, David Ricks, CoLucid Pharmaceuticals, Celgene, Gilead Sciences, GSK, Biogen
5 Things Biogen's CEO Just Said That You Don't Want to Miss
Motley Fool
Wed, 03/8/17 - 10:07 am
Tags:
Biogen, Pharma CEOs, Michel Vounatsos
​Biogen loses another top executive as tech guru departs
Bizjournals.com
Wed, 03/8/17 - 09:56 am
Tags:
Biogen
Big Pharma Is Losing a Fortune Trying to Cure Alzheimer's
Bloomberg
Thu, 03/2/17 - 10:16 am
Tags:
Alzheimer's disease, drug development, Roche, Merck, Eli Lilly, Biogen
Biogen alums team up to launch Waltham biotech, with backing from Henri Termeer
Bizjournals.com
Mon, 02/27/17 - 09:06 am
Tags:
Biogen, Pfizer, Henri Termeer, Arrakis Therapeutics
Top pharma lobbyist casts Biogen as the anti-Shkreli during drug price Q&A
Bizjournals.com
Tue, 02/21/17 - 10:26 pm
Tags:
Biogen, drug pricing, Martin Shkreli
Did Biogen Inc. Shoot Itself in the Foot?
Motley Fool
Tue, 02/21/17 - 11:11 am
Tags:
Biogen, drug pricing, Spinraza, SMA, spinal muscular atrophy
Top 25 rare disease brands, by sales
Medical Marketing and Media
Wed, 02/15/17 - 11:20 am
Tags:
rare disease, Copaxone, Teva Pharmaceutical, Avonex, Biogen, Sensipar, Soliris, Alexion, Xyrem, Jazz Pharmaceuticals
If copies of Teva's Copaxone hit, oral MS rivals could be the real threat
Fierce Pharma
Wed, 02/15/17 - 09:41 am
Tags:
Teva Pharmaceutical, Copaxone, MS, multiple sclerosis, generics, Tecfidera, Biogen, Gilenya, Novartis, Aubagio, Sanofi
Another US insurer places limits on Spinraza coverage
BioPharma Dive
Fri, 02/10/17 - 12:08 pm
Tags:
Biogen, Spinraza, spinal muscular atrophy, insurers, Humana
Biogen Reveals Federal Investigation Into Pricing, Rebate Payments
TheStreet.com
Fri, 02/3/17 - 10:10 am
Tags:
Biogen, drug pricing, rebates
Biogen's hemophilia business spin-off will trade on its own starting Thursday
Marketwatch
Wed, 02/1/17 - 10:34 am
Tags:
Biogen, spinoffs, Bioverativ, hemophilia
Biogen profit drops 22 pct due to Tecfidera-related costs
Yahoo/Reuters
Thu, 01/26/17 - 10:26 am
Tags:
Biogen, earnings, Tecfidera
Earnings preview: 7 biopharmas to watch
BioPharma Dive
Sat, 01/21/17 - 11:49 am
Tags:
earnings, JNJ, Novartis, Vertex Pharmaceuticals, Biogen, Celgene, Bristol-Myers Squibb, AbbVie
Biogen to pay $1.25B settlement in multiple sclerosis drug case
Bizjournals.com
Tue, 01/17/17 - 11:09 am
Tags:
Biogen, Tecfidera, Forward Pharma, MS, multiple sclerosis, patents
Biogen's latest drug may be costly, but new data suggests it saves lives
Bizjournals.com
Sat, 01/14/17 - 03:37 pm
Tags:
Biogen, Spinraza, SMA, spinal muscular atrophy
Biogen spinoff begins trading today; New oncology chief at AstraZeneca
Endpoints
Fri, 01/13/17 - 11:18 am
Tags:
Biogen, AstraZeneca, oncology, hemophilia, Bioverativ
Is Spinraza worth $750K? Biogen says yes, spelling out reduced death risk
Endpoints
Fri, 01/13/17 - 09:41 am
Tags:
Biogen, Spinraza, SMA, spinal muscular atrophy
3 Takeover Candidates in the Drug Space
TheStreet.com
Mon, 01/9/17 - 09:45 am
Tags:
M&A, Gilead Sciences, JNJ, Pfizer, Merck, Novartis, Eli Lilly, Bristol-Myers Squibb, Biogen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.